Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced its participation in a virtual fireside chat at the SVB Leerink Global Healthcare Conference on February 24, 2021, at 9:20 a.m. ET. The event will be accessible via the Investors tab on their website and will be archived for 14 days. Alkermes is a global biopharmaceutical company focused on medicine development in neuroscience and oncology, with a portfolio centered on addiction and schizophrenia treatments, and a pipeline targeting various disorders.

Positive

• Participation in a significant healthcare conference enhances visibility and investor engagement.
• The company has a diverse pipeline addressing critical therapeutic areas including addiction, schizophrenia, and oncology.

Negative

• None.

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the SVB Leerink Global Healthcare Conference on Wednesday, Feb. 24, 2021 at 9:20 a.m. ET (2:20 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-svb-leerink-10th-annual-global-healthcare-conference-301231128.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the SVB Leerink Global Healthcare Conference?

Alkermes will participate in the conference on February 24, 2021, at 9:20 a.m. ET.

How can I access Alkermes' presentation during the conference?

The presentation can be accessed under the Investors tab on Alkermes' website and will be archived for 14 days.

What areas does Alkermes focus on in its product pipeline?

Alkermes focuses on developing treatments for addiction, schizophrenia, bipolar disorder, neurodegenerative disorders, and cancer.

What is the stock symbol for Alkermes?

The stock symbol for Alkermes is ALKS.